The haunting of medical journals: how ghostwriting sold "HRT"

PLoS Med. 2010 Sep 7;7(9):e1000335. doi: 10.1371/journal.pmed.1000335.


Adriane Fugh-Berman examines documents unsealed in recent litigation to investigate how pharmaceutical companies promoted hormone therapy drugs, including the use of medical writing companies to produce ghostwritten manuscripts and place them into medical journals.

MeSH terms

  • Drug Industry
  • Editorial Policies
  • Hormone Replacement Therapy / standards*
  • Humans
  • Journalism, Medical*
  • Periodicals as Topic / legislation & jurisprudence
  • Scientific Misconduct / ethics*